S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
AAPL   265.76 (+1.19%)
FB   195.10 (+1.01%)
MSFT   149.97 (+1.29%)
GOOGL   1,333.54 (+1.86%)
AMZN   1,739.49 (-0.86%)
CGC   15.33 (-3.22%)
NVDA   204.19 (-2.67%)
MU   47.71 (+1.94%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
TSLA   352.17 (+0.81%)
T   39.50 (+1.41%)
AMD   38.56 (+0.55%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
NFLX   295.03 (+1.87%)
BAC   32.93 (+0.70%)
GILD   65.07 (+1.97%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
AAPL   265.76 (+1.19%)
FB   195.10 (+1.01%)
MSFT   149.97 (+1.29%)
GOOGL   1,333.54 (+1.86%)
AMZN   1,739.49 (-0.86%)
CGC   15.33 (-3.22%)
NVDA   204.19 (-2.67%)
MU   47.71 (+1.94%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
TSLA   352.17 (+0.81%)
T   39.50 (+1.41%)
AMD   38.56 (+0.55%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
NFLX   295.03 (+1.87%)
BAC   32.93 (+0.70%)
GILD   65.07 (+1.97%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
AAPL   265.76 (+1.19%)
FB   195.10 (+1.01%)
MSFT   149.97 (+1.29%)
GOOGL   1,333.54 (+1.86%)
AMZN   1,739.49 (-0.86%)
CGC   15.33 (-3.22%)
NVDA   204.19 (-2.67%)
MU   47.71 (+1.94%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
TSLA   352.17 (+0.81%)
T   39.50 (+1.41%)
AMD   38.56 (+0.55%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
NFLX   295.03 (+1.87%)
BAC   32.93 (+0.70%)
GILD   65.07 (+1.97%)
DIS   144.67 (-1.69%)
S&P 500   3,120.46 (+0.77%)
DOW   28,004.89 (+0.80%)
QQQ   202.91 (+0.73%)
AAPL   265.76 (+1.19%)
FB   195.10 (+1.01%)
MSFT   149.97 (+1.29%)
GOOGL   1,333.54 (+1.86%)
AMZN   1,739.49 (-0.86%)
CGC   15.33 (-3.22%)
NVDA   204.19 (-2.67%)
MU   47.71 (+1.94%)
BABA   185.49 (+1.47%)
GE   11.52 (+2.04%)
TSLA   352.17 (+0.81%)
T   39.50 (+1.41%)
AMD   38.56 (+0.55%)
ACB   2.73 (-17.02%)
F   8.95 (+1.82%)
PRI   130.62 (+0.32%)
NFLX   295.03 (+1.87%)
BAC   32.93 (+0.70%)
GILD   65.07 (+1.97%)
DIS   144.67 (-1.69%)
Log in

Rewalk Robotics Stock Price, Forecast & Analysis (NASDAQ:RWLK)

$2.09
-0.15 (-6.70 %)
(As of 11/15/2019 04:00 PM ET)
Today's Range
$1.94
Now: $2.09
$2.20
50-Day Range
$2.20
MA: $2.83
$3.17
52-Week Range
$1.94
Now: $2.09
$10.08
Volume328,700 shs
Average Volume555,356 shs
Market Capitalization$15.23 million
P/E RatioN/A
Dividend YieldN/A
Beta1.56
ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes exoskeletons for wheelchair-bound individuals with mobility impairments or other medical conditions. The company offers ReWalk Personal for everyday use to paraplegic individuals at home and in their communities; and ReWalk Rehabilitation for exercise and therapy used in hospitals and rehabilitation centers in the United States and Europe. Read More…

Industry, Sector and Symbol

Industry Surgical appliances & supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:RWLK
CUSIPN/A
Phone972-4959-0123

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$6.55 million
Book Value$0.69 per share

Profitability

Net Income$-21,670,000.00
Net Margins-320.80%

Miscellaneous

Employees58
Market Cap$15.23 million
Next Earnings Date2/14/2020 (Estimated)
OptionableNot Optionable

Receive RWLK News and Ratings via Email

Sign-up to receive the latest news and ratings for RWLK and its competitors with MarketBeat's FREE daily newsletter.


Rewalk Robotics (NASDAQ:RWLK) Frequently Asked Questions

What is Rewalk Robotics' stock symbol?

Rewalk Robotics trades on the NASDAQ under the ticker symbol "RWLK."

How were Rewalk Robotics' earnings last quarter?

Rewalk Robotics Ltd (NASDAQ:RWLK) released its earnings results on Wednesday, November, 13th. The medical device company reported ($0.46) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.45) by $0.01. The medical device company earned $1.23 million during the quarter, compared to analysts' expectations of $3.27 million. Rewalk Robotics had a negative net margin of 320.80% and a negative return on equity of 452.23%. View Rewalk Robotics' Earnings History.

When is Rewalk Robotics' next earnings date?

Rewalk Robotics is scheduled to release their next quarterly earnings announcement on Friday, February 14th 2020. View Earnings Estimates for Rewalk Robotics.

What price target have analysts set for RWLK?

1 Wall Street analysts have issued 12 month target prices for Rewalk Robotics' shares. Their forecasts range from $9.00 to $9.00. On average, they anticipate Rewalk Robotics' stock price to reach $9.00 in the next year. This suggests a possible upside of 330.6% from the stock's current price. View Analyst Price Targets for Rewalk Robotics.

What is the consensus analysts' recommendation for Rewalk Robotics?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Rewalk Robotics in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Rewalk Robotics.

Has Rewalk Robotics been receiving favorable news coverage?

Headlines about RWLK stock have been trending neutral this week, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Rewalk Robotics earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned press coverage about the medical device company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Rewalk Robotics.

Are investors shorting Rewalk Robotics?

Rewalk Robotics saw a increase in short interest during the month of October. As of October 31st, there was short interest totalling 382,200 shares, an increase of 6.2% from the September 30th total of 359,800 shares. Based on an average trading volume of 118,100 shares, the short-interest ratio is presently 3.2 days. Approximately 5.8% of the shares of the company are short sold. View Rewalk Robotics' Current Options Chain.

Who are some of Rewalk Robotics' key competitors?

What other stocks do shareholders of Rewalk Robotics own?

Who are Rewalk Robotics' key executives?

Rewalk Robotics' management team includes the folowing people:
  • Mr. Lawrence J. Jasinski, CEO & Director (Age 62)
  • Mr. Ori Gon, Chief Financial Officer (Age 38)
  • Ms. Miri Pariente, VP of QA & Operations (Age 42)
  • Mr. Loren Wass, VP of Sales & Reimbursement
  • Mr. Andy Dolan, VP of Marketing

Who are Rewalk Robotics' major shareholders?

Rewalk Robotics' stock is owned by many different of institutional and retail investors. Top institutional shareholders include FNY Investment Advisers LLC (3.09%). Company insiders that own Rewalk Robotics stock include Lawrence J Jasinski and Ofir Koren. View Institutional Ownership Trends for Rewalk Robotics.

Which major investors are buying Rewalk Robotics stock?

RWLK stock was acquired by a variety of institutional investors in the last quarter, including FNY Investment Advisers LLC. View Insider Buying and Selling for Rewalk Robotics.

How do I buy shares of Rewalk Robotics?

Shares of RWLK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Rewalk Robotics' stock price today?

One share of RWLK stock can currently be purchased for approximately $2.09.

How big of a company is Rewalk Robotics?

Rewalk Robotics has a market capitalization of $15.23 million and generates $6.55 million in revenue each year. The medical device company earns $-21,670,000.00 in net income (profit) each year or ($14.75) on an earnings per share basis. Rewalk Robotics employs 58 workers across the globe.View Additional Information About Rewalk Robotics.

What is Rewalk Robotics' official website?

The official website for Rewalk Robotics is http://www.rewalk.com/.

How can I contact Rewalk Robotics?

Rewalk Robotics' mailing address is 3 Hatnufa Street Floor 6, Yokneam Ilit L3, 2069203. The medical device company can be reached via phone at 972-4959-0123 or via email at [email protected]


MarketBeat Community Rating for Rewalk Robotics (NASDAQ RWLK)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  318 (Vote Outperform)
Underperform Votes:  242 (Vote Underperform)
Total Votes:  560
MarketBeat's community ratings are surveys of what our community members think about Rewalk Robotics and other stocks. Vote "Outperform" if you believe RWLK will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RWLK will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/15/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel